Science & Research

New York City-based Mind Medicine announced it had partnered with the world-leading psychedelics pharmacology and clinical research laboratory at University Hospital Basel in Switzerland.

Canadian cannabis healthcare technology company Cannalogue has applied to conduct clinical trials investigating potential cannabis-based treatments for COVID-19.

Researchers at the University of Southern Denmark have uncovered evidence that CBD can help antibiotics in the fight against antibiotic-resistant bacteria.

The DEA has unveiled a new rule proposal that would finally open up the licensing of new research-grade cannabis cultivators.

The UCLA Cannabis Research Initiative has been awarded a $3.9 million grant to investigate whether cannabis terpenes can help reduce the use of opioids in pain treatment.

A study published last month shows that cannabis could be an effective and safer alternative treatment for fibromyalgia symptoms.

A staggering majority of California patients who suffered from lung injury associated with vaping (EVALI) acquired their products from illegal sources, a new study shows.

A recent study examined CBD’s effectiveness against the neurotoxicity of hydrogen peroxide (H₂O₂), a molecule that has been considered as a potential culprit in severe pathological conditions such as cancer, strokes, and neurodegenerative diseases.

Researchers at McMaster University in Canada have discovered that cannabigerol (CBG) is capable of defeating MRSA, an infection infamously resistant to many traditional antibiotics.

A recent study shows that not only do bees love the pollen from cannabis and hemp plants, but other direct benefits from the plant could help to protect their dwindling populations.

A recent study suggests that patients with ADHD who use medical cannabis are likely to rely less on prescription medications.

A recent study found that people under the influence of cannabis are more susceptible to false memories.

The Colorado Commission on Higher Education has approved the state’s first cannabis degree program, a bachelor of science in cannabis biology and chemistry at Colorado State University-Pueblo.

Colorado State University has received a $1.5 million donation from Panacea Life Sciences CEO Leslie Buttorff to fund cannabinoid research.

A recent study suggests that while cannabis use has increased among college students in states that have legalized, binge drinking of alcohol has decreased among students.

The House Energy and Commerce health subcommittee will meet today to discuss the ongoing federal barriers to cannabis research.

The Global Hemp Innovation Center operated by Oregon State University will receive $2.5 million from the federal government earmarked as part of a larger federal funding bill.

THCP, a cannabinoid recently discovered by Italian researchers, appears to have an affinity for CB1 receptors that is “more than thirty-fold higher” than that of THC.

Do dogs react differently to CBD oil than people do? How do pet owners know what methods and doses for CBD oils are safe for their four-legged friends? Explore more about the benefits and side effects of CBD oil for dogs in this article.

A recently published study, which spanned 12 years, suggests that people who experience depression may be twice as likely to consume cannabis.

A recent study from the Centre for Addiction and Mental Health in Toronto has debunked a myth that cannabis can influence drivers up to 24 and even 48 hours after consumption.

Canadian cannabis producer Atlas Biotechnologies has awarded a $300,000 grant to University of Alberta researchers for the investigation of cannabis as a potential therapy for multiple sclerosis (MS), Alzheimer’s disease, and Huntington’s disease.

Researchers at Washington State University have demonstrated strong economic disparities in the neighborhood distribution of cannabis businesses in a recent study.

A self-reported cannabis consumer study from Washington State University suggests that inhaled cannabis products reduce the severity of headaches and migraines by 49.6 percent and 47.3 percent, respectively.